Clinical Research Directory
Browse clinical research sites, groups, and studies.
Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
Sponsor: IRCCS San Raffaele
Summary
This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, adjuvant, or salvage purposes in patients with low, intermediate, high, and very high-risk prostate cancer, or with biochemical, lymph node, or oligometastatic recurrence treated between 2004 and 2024. Approved by Ethics Committee of IRCCS San Raffaele Hospital Approval Number: 187/INT/2021, 03/02/2022 Amendment approved by Ethics Committee 1, Lombardy Region Approval number CET Em. 194-2024, 22/05/2024
Official title: Efficacy of Advanced Radiotherapy (ART) in Prostate Cancer Patients With Early Stage, Advanced, Metastatic and Relapsed Disease (PROST-ART)
Key Details
Gender
MALE
Age Range
18 Years - 95 Years
Study Type
OBSERVATIONAL
Enrollment
2500
Start Date
2022-02-14
Completion Date
2027-12-14
Last Updated
2025-06-11
Healthy Volunteers
Not specified
Conditions
Interventions
Image Guided Radiotherapy
Patients treated with IGRT for Prostate cancer will be evaluated
Intensity Modulated Radiotherapy
Patients treated with IMRT for Prostate cancer will be evaluated
Stereotactic Body Radiotherapy
Patients treated with SBRT for Prostate cancer will be evaluated
Locations (1)
IRCCS San Raffaele Scientific Institute
Milan, Italy